Excited to share our latest methods review on senescence! 🧬We map apoptotic dependencies in senescent cells using BH3 profiling + p16/p21 to guide senolytics. Targeting BCL‑2 family could boost clearance & therapy outcomes. @ub.edu @idibaps.bsky.social authors.elsevier.com/a/1nHlF,25QI...

#InternationalChildhoodCancerDay we raise awareness, honor children and families, & reaffirm our commitment to science that saves live by continue working to develop tools that improve therapeutic decision‑making to bring the best treatment to every child www.themonterolab.com

On #WorldCancerDay, we reaffirm our dedication to understand how cancers develop resistance to therapy and to advancing new functional precision medicine technologies to overcome it. Our mission remains clear: to drive the discovery of more effective treatments for adult and pediatric cancers.

Gracias por todas esas canciones que han marcado un antes y un después en mi vida. DEP Robe

Are you attending the American Society of Hematology meeting? Don't miss this session led by SfPM member Dr. Pamela Becker and St. Jude's Integrating Functional and Genomic Precision Medicine for Hematologic Malignancies. Friday, December 5, 2025, 3:00-6:00 PM

Happy Thanksgiving to all my American friends!

Congratulations @senescel.org for this great meeting! Total success! Dr. Clara Alcon presented our work focused on TIS-mediated resistance, and how to detect it using BH3 profiling and overcome it targeting anti-apoptotic proteins. Can’t wait for the next meeting!

🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM www.sfpm.io/seminars

#RecercaUB | 🧠 Un nou estudi aconsegueix revertir els efectes de l’Alzheimer en ratolins amb l’ús de nanopartícules portadores de molècules terapèutiques. 🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.

Congratulations Tony! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing news!

A must watch video: How functional precision medicine could be the future of cancer care. Truly inspiring TED talk by Dr. Diana Azzam www.youtube.com/watch?v=CqLC...

Delighted to see good research highlighted on TV @som.3cat.cat Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients. www.3cat.cat/324/cancer-d...

This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage. It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️ Rush to register at senescel2025.senescel.org

✨ Excited to announce a talk by Rita Fior, PhD on "Zebrafish Avatars for Personalized Medicine & Discovery of Innate Immune Mechanisms"! Join us next Wednesday, July 9, 2025, at 12 PM EDT, organized by @thesfpm.bsky.social. Don't miss it! www.sfpm.io/seminars

🚨 New Article Alert! Dive into a fantastic review by several @thesfpm.bsky.social members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight! www.nature.com/articles/s41...

Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations doi.org/10.1158/2159...#AACR25

Quote of the day: “If you think research is expensive, try disease.” Mary Lasker

Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Read the summary here: web.ub.edu/en/web/actua...

Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Congratulations to Dr. Martín and to all our collaborators @ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN rdcu.be/eennu

Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social www.sfpm.io/seminars

Happy International Women’s day to all the brave, intelligent, loving, amazing women worldwide!

🚀 Exciting news! Our new research lab website is live! 🌐 Explore cutting-edge projects, publications, and more. Visit us at themonterolab.com

Papers on cell death from January 2025 Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more! ApoList celldeath.wordpress.com/2025/02/04/a...

On #WorldCancerDay #WCD2025 and every day, our lab is committed to finding a cure for cancer through groundbreaking research and advanced functional precision medicine. Together, we can find a treatment for each patient and beat cancer @ub.edu @thesfpm.bsky.social

An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML ashpublications.org/blood/articl...

#RecercaUB | 🔬 Un estudi liderat per la #UniBarcelona descriu un mecanisme per eliminar les cèl·lules perjudicials originades per tractaments oncològics 📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social. 👉 web.ub.edu/web/actualit...

Thrilled to receive the prestigious ICREA Acadèmia award! A heartfelt thank you to everyone at @ub.edu & ICREA - Institució Catalana de Recerca i Estudis Avançats who made this possible.

Proud to share three papers from our lab rdcu.be/d2hUm @ub.edu , Letai lab rdcu.be/d5rb3, and R. Bernards rdcu.be/d5rjW all showing predictable mitochondrial control of senescent cell death, using BH3 profiling as a biomarker for senolytic therapy.

Join us *tomorrow* Wednesday 12/11 @ 12:00 PM EST for our last monthly SFPM seminar of the year! Drs. Damle and Pillarisetty from @fredhutch.bsky.social will discuss tumor slice cultures as a window into the human TME. Info to join here: www.sfpm.io/seminars

We have a new PhD in town! Congratulations Dr. Fernando Martín! @ub.edu

We're looking for a hard working and ambitious postdoc to join our lab studying cell death in cancer, development, toxicology, neurodegeneration and beyond! We strive to maintain a diverse, inclusive and collaborative work environment. Apply now at sarosieklab.org!